Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (5227)	8/26/1998 9:49:00 PM
From: BigKNY3	Read Replies (2) \| Respond to of 9523

Today's French News: Pfizer's Viagra will be on sale in France from mid-October (Le Viagra de Pfizer sera en vente en France a partir de la mi-octobre) 08/26/98 Les Echos Page 7 Abstracted from Les Echos in French; Source: World Reporter (TM) The medicine against impotence, Viagra, developed by American pharmaceuticals company Pfizer, is already in high demand in Asia and the US. Following the latest meeting of European scientific experts in Brussels, Viagra is expected to be officially authorised on 15 September in Europe. The "love pill" is expected to be on sale in the European countries which did not ask for its refund by health authorities (Southern European countries, Belgium and France), a few weeks later. Pfizer France hopes to sale the product in France from the middle of October, leaving the company enough time to print instruction leaflets and package the pills in its Amboise factory (Indre-et-Loire region).